Engineering Animals to Grow Human Organs — But Not Human Minds
By Charles Schmidt,
Undark
| 09. 25. 2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a physician-scientist who also holds an academic appointment at Stanford University. Nakauchi specializes in developing “chimeric” animals made up of cells from different species. This unprecedented feat proved that an entire organ from one kind of animal can be grown within another. The chimeras had been generated as early-stage embryos that, after being implanted into surrogate mothers, came to term “just as in normal mouse pregnancy,” Nakauchi wrote in an emailed response to questions.
Nakauchi’s Japanese lab, now at the Institute of Science Tokyo, a public research university, hit another milestone this year by producing litters of baby mice that were partly human. Currently under review at the journal Nature Biomedical Engineering, the experiment is the first instance of pregnancies involving human-animal chimeras resulting in live births. The human cells were integrated with the animals’ blood vessels and heart muscles, showing...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...